Publications
- Therapeutic potential and limitations of curcumin as antimetastatic agent2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration2022 | First Faculty of Medicine, Faculty of Science
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
- Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators2022 | First Faculty of Medicine
- Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells2022 | First Faculty of Medicine
- Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design2021 | First Faculty of Medicine
- Versatile fluorophores for bioimaging applications: pi-expanded naphthalimide derivatives with skeletal and appendage diversity2019 | First Faculty of Medicine
- Pentamethinium salts as ligands for cancer: Sulfated polysaccharide co-receptors as possible therapeutic target2019 | First Faculty of Medicine
- Hydrazones as novel epigenetic modulators: Correlation between TET 1 protein inhibition activity and their iron(II) binding ability2019 | First Faculty of Medicine
Loading network view...